aluates Reports

$ 0.0

Automative

Global Fatty Liver Drugs Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-37L12740

Global Fatty Liver Drugs Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Global Fatty Liver Drugs Market Research Report 2025

Code: QYRE-Auto-37L12740

Report

July 2025

Pages:83

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Immuron

Novartis

Takeda

Allergan plc

Intercept Pharmaceuticals

Conatus

Merk

Madrigal

Hepion Pharmaceuticals

Astra Zenca

Gilead Sciences

Pfizer Inc

Fatty Liver Drugs Market Size

The global market for Fatty Liver Drugs was valued at US$ 23070 million in the year 2024 and is projected to reach a revised size of US$ 32730 million by 2031, growing at a CAGR of 5.2% during the forecast period.

Fatty Liver Drugs Market

Fatty liver drugs refer to medications or pharmaceutical treatments used in the management and treatment of fatty liver disease. Fatty liver disease, also known as hepatic steatosis, is a condition characterized by the accumulation of excess fat in the liver cells.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Fatty Liver Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fatty Liver Drugs.

The Fatty Liver Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fatty Liver Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Fatty Liver Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Fatty Liver Drugs Market Report

Report Metric	Details
Report Name	Fatty Liver Drugs Market
Accounted market size in year	US$ 23070 million
Forecasted market size in 2031	US$ 32730 million
CAGR	5.2%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	ALD NAFLD
Segment by Application	Hospital Clinic Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Gilead Sciences, Astra Zenca, Immuron, Novartis, Takeda, Allergan, Intercept Pharmaceuticals, Conatus, Merk, Madrigal, Hepion Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Fatty Liver Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Fatty Liver Drugs Market growing?

Ans: The Fatty Liver Drugs Market witnessing a CAGR of 5.2% during the forecast period 2025-2031.

What is the Fatty Liver Drugs Market size in 2031?

Ans: The Fatty Liver Drugs Market size in 2031 will be US$ 32730 million.

Who are the main players in the Fatty Liver Drugs Market report?

Ans: The main players in the Fatty Liver Drugs Market are Pfizer, Gilead Sciences, Astra Zenca, Immuron, Novartis, Takeda, Allergan, Intercept Pharmaceuticals, Conatus, Merk, Madrigal, Hepion Pharmaceuticals

What are the Application segmentation covered in the Fatty Liver Drugs Market report?

Ans: The Applications covered in the Fatty Liver Drugs Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Fatty Liver Drugs Market report?

Ans: The Types covered in the Fatty Liver Drugs Market report are ALD, NAFLD

Recommended Reports

Liver Disease Treatments

Metabolic & Cardiovascular Drugs

Hepatitis & Related Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Fatty Liver Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 ALD

1.2.3 NAFLD

1.3 Market by Application

1.3.1 Global Fatty Liver Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Fatty Liver Drugs Market Perspective (2020-2031)

2.2 Global Fatty Liver Drugs Growth Trends by Region

2.2.1 Global Fatty Liver Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Fatty Liver Drugs Historic Market Size by Region (2020-2025)

2.2.3 Fatty Liver Drugs Forecasted Market Size by Region (2026-2031)

2.3 Fatty Liver Drugs Market Dynamics

2.3.1 Fatty Liver Drugs Industry Trends

2.3.2 Fatty Liver Drugs Market Drivers

2.3.3 Fatty Liver Drugs Market Challenges

2.3.4 Fatty Liver Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Fatty Liver Drugs Players by Revenue

3.1.1 Global Top Fatty Liver Drugs Players by Revenue (2020-2025)

3.1.2 Global Fatty Liver Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Fatty Liver Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Fatty Liver Drugs Revenue

3.4 Global Fatty Liver Drugs Market Concentration Ratio

3.4.1 Global Fatty Liver Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Fatty Liver Drugs Revenue in 2024

3.5 Global Key Players of Fatty Liver Drugs Head office and Area Served

3.6 Global Key Players of Fatty Liver Drugs, Product and Application

3.7 Global Key Players of Fatty Liver Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Fatty Liver Drugs Breakdown Data by Type

4.1 Global Fatty Liver Drugs Historic Market Size by Type (2020-2025)

4.2 Global Fatty Liver Drugs Forecasted Market Size by Type (2026-2031)

5 Fatty Liver Drugs Breakdown Data by Application

5.1 Global Fatty Liver Drugs Historic Market Size by Application (2020-2025)

5.2 Global Fatty Liver Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Fatty Liver Drugs Market Size (2020-2031)

6.2 North America Fatty Liver Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Fatty Liver Drugs Market Size by Country (2020-2025)

6.4 North America Fatty Liver Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Fatty Liver Drugs Market Size (2020-2031)

7.2 Europe Fatty Liver Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Fatty Liver Drugs Market Size by Country (2020-2025)

7.4 Europe Fatty Liver Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Fatty Liver Drugs Market Size (2020-2031)

8.2 Asia-Pacific Fatty Liver Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Fatty Liver Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Fatty Liver Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Fatty Liver Drugs Market Size (2020-2031)

9.2 Latin America Fatty Liver Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Fatty Liver Drugs Market Size by Country (2020-2025)

9.4 Latin America Fatty Liver Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Fatty Liver Drugs Market Size (2020-2031)

10.2 Middle East & Africa Fatty Liver Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Fatty Liver Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Fatty Liver Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Fatty Liver Drugs Introduction

11.1.4 Pfizer Revenue in Fatty Liver Drugs Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Gilead Sciences

11.2.1 Gilead Sciences Company Details

11.2.2 Gilead Sciences Business Overview

11.2.3 Gilead Sciences Fatty Liver Drugs Introduction

11.2.4 Gilead Sciences Revenue in Fatty Liver Drugs Business (2020-2025)

11.2.5 Gilead Sciences Recent Development

11.3 Astra Zenca

11.3.1 Astra Zenca Company Details

11.3.2 Astra Zenca Business Overview

11.3.3 Astra Zenca Fatty Liver Drugs Introduction

11.3.4 Astra Zenca Revenue in Fatty Liver Drugs Business (2020-2025)

11.3.5 Astra Zenca Recent Development

11.4 Immuron

11.4.1 Immuron Company Details

11.4.2 Immuron Business Overview

11.4.3 Immuron Fatty Liver Drugs Introduction

11.4.4 Immuron Revenue in Fatty Liver Drugs Business (2020-2025)

11.4.5 Immuron Recent Development

11.5 Novartis

11.5.1 Novartis Company Details

11.5.2 Novartis Business Overview

11.5.3 Novartis Fatty Liver Drugs Introduction

11.5.4 Novartis Revenue in Fatty Liver Drugs Business (2020-2025)

11.5.5 Novartis Recent Development

11.6 Takeda

11.6.1 Takeda Company Details

11.6.2 Takeda Business Overview

11.6.3 Takeda Fatty Liver Drugs Introduction

11.6.4 Takeda Revenue in Fatty Liver Drugs Business (2020-2025)

11.6.5 Takeda Recent Development

11.7 Allergan

11.7.1 Allergan Company Details

11.7.2 Allergan Business Overview

11.7.3 Allergan Fatty Liver Drugs Introduction

11.7.4 Allergan Revenue in Fatty Liver Drugs Business (2020-2025)

11.7.5 Allergan Recent Development

11.8 Intercept Pharmaceuticals

11.8.1 Intercept Pharmaceuticals Company Details

11.8.2 Intercept Pharmaceuticals Business Overview

11.8.3 Intercept Pharmaceuticals Fatty Liver Drugs Introduction

11.8.4 Intercept Pharmaceuticals Revenue in Fatty Liver Drugs Business (2020-2025)

11.8.5 Intercept Pharmaceuticals Recent Development

11.9 Conatus

11.9.1 Conatus Company Details

11.9.2 Conatus Business Overview

11.9.3 Conatus Fatty Liver Drugs Introduction

11.9.4 Conatus Revenue in Fatty Liver Drugs Business (2020-2025)

11.9.5 Conatus Recent Development

11.10 Merk

11.10.1 Merk Company Details

11.10.2 Merk Business Overview

11.10.3 Merk Fatty Liver Drugs Introduction

11.10.4 Merk Revenue in Fatty Liver Drugs Business (2020-2025)

11.10.5 Merk Recent Development

11.11 Madrigal

11.11.1 Madrigal Company Details

11.11.2 Madrigal Business Overview

11.11.3 Madrigal Fatty Liver Drugs Introduction

11.11.4 Madrigal Revenue in Fatty Liver Drugs Business (2020-2025)

11.11.5 Madrigal Recent Development

11.12 Hepion Pharmaceuticals

11.12.1 Hepion Pharmaceuticals Company Details

11.12.2 Hepion Pharmaceuticals Business Overview

11.12.3 Hepion Pharmaceuticals Fatty Liver Drugs Introduction

11.12.4 Hepion Pharmaceuticals Revenue in Fatty Liver Drugs Business (2020-2025)

11.12.5 Hepion Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Immuron

Novartis

Takeda

Allergan plc

Intercept Pharmaceuticals

Conatus

Merk

Madrigal

Hepion Pharmaceuticals

Astra Zenca

Gilead Sciences

Pfizer Inc

List of Tables

Table 1. Global Fatty Liver Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of ALD

Table 3. Key Players of NAFLD

Table 4. Global Fatty Liver Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Fatty Liver Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Fatty Liver Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Fatty Liver Drugs Market Share by Region (2020-2025)

Table 8. Global Fatty Liver Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Fatty Liver Drugs Market Share by Region (2026-2031)

Table 10. Fatty Liver Drugs Market Trends

Table 11. Fatty Liver Drugs Market Drivers

Table 12. Fatty Liver Drugs Market Challenges

Table 13. Fatty Liver Drugs Market Restraints

Table 14. Global Fatty Liver Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Fatty Liver Drugs Market Share by Players (2020-2025)

Table 16. Global Top Fatty Liver Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Drugs as of 2024)

Table 17. Ranking of Global Top Fatty Liver Drugs Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Fatty Liver Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Fatty Liver Drugs, Headquarters and Area Served

Table 20. Global Key Players of Fatty Liver Drugs, Product and Application

Table 21. Global Key Players of Fatty Liver Drugs, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Fatty Liver Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Fatty Liver Drugs Revenue Market Share by Type (2020-2025)

Table 25. Global Fatty Liver Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Fatty Liver Drugs Revenue Market Share by Type (2026-2031)

Table 27. Global Fatty Liver Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Fatty Liver Drugs Revenue Market Share by Application (2020-2025)

Table 29. Global Fatty Liver Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Fatty Liver Drugs Revenue Market Share by Application (2026-2031)

Table 31. North America Fatty Liver Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Fatty Liver Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Fatty Liver Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Fatty Liver Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Fatty Liver Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Fatty Liver Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Fatty Liver Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Fatty Liver Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Fatty Liver Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Fatty Liver Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Fatty Liver Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Fatty Liver Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Fatty Liver Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Fatty Liver Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Fatty Liver Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Pfizer Company Details

Table 47. Pfizer Business Overview

Table 48. Pfizer Fatty Liver Drugs Product

Table 49. Pfizer Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 50. Pfizer Recent Development

Table 51. Gilead Sciences Company Details

Table 52. Gilead Sciences Business Overview

Table 53. Gilead Sciences Fatty Liver Drugs Product

Table 54. Gilead Sciences Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 55. Gilead Sciences Recent Development

Table 56. Astra Zenca Company Details

Table 57. Astra Zenca Business Overview

Table 58. Astra Zenca Fatty Liver Drugs Product

Table 59. Astra Zenca Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 60. Astra Zenca Recent Development

Table 61. Immuron Company Details

Table 62. Immuron Business Overview

Table 63. Immuron Fatty Liver Drugs Product

Table 64. Immuron Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 65. Immuron Recent Development

Table 66. Novartis Company Details

Table 67. Novartis Business Overview

Table 68. Novartis Fatty Liver Drugs Product

Table 69. Novartis Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 70. Novartis Recent Development

Table 71. Takeda Company Details

Table 72. Takeda Business Overview

Table 73. Takeda Fatty Liver Drugs Product

Table 74. Takeda Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 75. Takeda Recent Development

Table 76. Allergan Company Details

Table 77. Allergan Business Overview

Table 78. Allergan Fatty Liver Drugs Product

Table 79. Allergan Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 80. Allergan Recent Development

Table 81. Intercept Pharmaceuticals Company Details

Table 82. Intercept Pharmaceuticals Business Overview

Table 83. Intercept Pharmaceuticals Fatty Liver Drugs Product

Table 84. Intercept Pharmaceuticals Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 85. Intercept Pharmaceuticals Recent Development

Table 86. Conatus Company Details

Table 87. Conatus Business Overview

Table 88. Conatus Fatty Liver Drugs Product

Table 89. Conatus Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 90. Conatus Recent Development

Table 91. Merk Company Details

Table 92. Merk Business Overview

Table 93. Merk Fatty Liver Drugs Product

Table 94. Merk Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 95. Merk Recent Development

Table 96. Madrigal Company Details

Table 97. Madrigal Business Overview

Table 98. Madrigal Fatty Liver Drugs Product

Table 99. Madrigal Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 100. Madrigal Recent Development

Table 101. Hepion Pharmaceuticals Company Details

Table 102. Hepion Pharmaceuticals Business Overview

Table 103. Hepion Pharmaceuticals Fatty Liver Drugs Product

Table 104. Hepion Pharmaceuticals Revenue in Fatty Liver Drugs Business (2020-2025) & (US$ Million)

Table 105. Hepion Pharmaceuticals Recent Development

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

Table 109. Authors List of This Report

List of Figures

Figure 1. Fatty Liver Drugs Picture

Figure 2. Global Fatty Liver Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Fatty Liver Drugs Market Share by Type: 2024 VS 2031

Figure 4. ALD Features

Figure 5. NAFLD Features

Figure 6. Global Fatty Liver Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Fatty Liver Drugs Market Share by Application: 2024 VS 2031

Figure 8. Hospital Case Studies

Figure 9. Clinic Case Studies

Figure 10. Others Case Studies

Figure 11. Fatty Liver Drugs Report Years Considered

Figure 12. Global Fatty Liver Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 13. Global Fatty Liver Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Fatty Liver Drugs Market Share by Region: 2024 VS 2031

Figure 15. Global Fatty Liver Drugs Market Share by Players in 2024

Figure 16. Global Top Fatty Liver Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fatty Liver Drugs as of 2024)

Figure 17. The Top 10 and 5 Players Market Share by Fatty Liver Drugs Revenue in 2024

Figure 18. North America Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 19. North America Fatty Liver Drugs Market Share by Country (2020-2031)

Figure 20. United States Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. Canada Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Europe Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Fatty Liver Drugs Market Share by Country (2020-2031)

Figure 24. Germany Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. France Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. U.K. Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Italy Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Russia Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Nordic Countries Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Asia-Pacific Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Fatty Liver Drugs Market Share by Region (2020-2031)

Figure 32. China Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Japan Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. South Korea Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Southeast Asia Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. India Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Australia Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Latin America Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Fatty Liver Drugs Market Share by Country (2020-2031)

Figure 40. Mexico Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Brazil Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Middle East & Africa Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Fatty Liver Drugs Market Share by Country (2020-2031)

Figure 44. Turkey Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Saudi Arabia Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. UAE Fatty Liver Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Pfizer Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 48. Gilead Sciences Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 49. Astra Zenca Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 50. Immuron Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 52. Takeda Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 53. Allergan Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 54. Intercept Pharmaceuticals Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 55. Conatus Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 56. Merk Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 57. Madrigal Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 58. Hepion Pharmaceuticals Revenue Growth Rate in Fatty Liver Drugs Business (2020-2025)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Non Alcoholic Steatohepatitis Therapeutics and Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Lipid Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lipid Metabolism Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lipid Metabolism Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lipid Metabolism Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Non Alcoholic Steatohepatitis Treatment Market Research Report 2025

Global Non Alcoholic Fatty Liver Disease Treatment Market Research Report 2024

Nonalcoholic Steatohepatitis NASH Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Antihyperlipidemic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nonalcoholic Steatohepatitis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Nonalcoholic Steatohepatitis Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Non alcoholic Steatohepatitis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Alcoholic Hepatitis Treatment Market Insights Forecast to 2030

Metabolic Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Hepatitis C Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Metabolic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drugs for Metabolic Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Metabolism Drugs Market Research Report 2025

Hepatitis C Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Drug-Free Pain Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33I16356

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Adult Artificial Heart Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-32W16534

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Viral Vector Vaccine for Humans Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-23Z16367

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Cardioplegia Adapter Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33A16598

Thu Sep 25 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions